Early diagnosis of tumor processes
Novel Scanning Flow Cytometry technology will allow detecting and analysis of circulating tumor cells, which will help to predict patient conditions in the early stages and determine appropriate individual treatment. Detection of such cells has several advantages over traditional tissue biopsy methods, they are non-invasive, can be reused and provide more useful information about the risk of metastasis.